Hoa Chu

Hoa Chu is a seasoned professional in the pharmaceutical and biotechnology industries, currently serving as the Director of Medical Information & Communications at Puma Biotechnology, Inc. since May 2025. Prior experience includes roles at Bristol Myers Squibb as Associate Scientific Director in US Medical Affairs for Lymphoma, and at ADC Therapeutics as Senior Medical Science Liaison. Hoa Chu has a proven track record at Astellas Pharma in oncology and has contributed significantly to product launches and medical affairs at Gilead Sciences, where responsibilities included revising standard response documents and ensuring scientific accuracy in marketing materials. Earlier career experience encompasses a position at Nephron Pharmaceuticals, focusing on drug and device safety. Hoa Chu holds a Doctor of Pharmacy degree from the University of Rhode Island.